These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 33665637)

  • 1. Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoediting.
    Schmidt J; Smith AR; Magnin M; Racle J; Devlin JR; Bobisse S; Cesbron J; Bonnet V; Carmona SJ; Huber F; Ciriello G; Speiser DE; Bassani-Sternberg M; Coukos G; Baker BM; Harari A; Gfeller D
    Cell Rep Med; 2021 Feb; 2(2):100194. PubMed ID: 33665637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting CD4 T-cell epitopes based on antigen cleavage, MHCII presentation, and TCR recognition.
    Schneidman-Duhovny D; Khuri N; Dong GQ; Winter MB; Shifrut E; Friedman N; Craik CS; Pratt KP; Paz P; Aswad F; Sali A
    PLoS One; 2018; 13(11):e0206654. PubMed ID: 30399156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the feasibility of mining CD8+ T cell receptor patterns underlying immunogenic peptide recognition.
    De Neuter N; Bittremieux W; Beirnaert C; Cuypers B; Mrzic A; Moris P; Suls A; Van Tendeloo V; Ogunjimi B; Laukens K; Meysman P
    Immunogenetics; 2018 Mar; 70(3):159-168. PubMed ID: 28779185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved predictions of antigen presentation and TCR recognition with MixMHCpred2.2 and PRIME2.0 reveal potent SARS-CoV-2 CD8
    Gfeller D; Schmidt J; Croce G; Guillaume P; Bobisse S; Genolet R; Queiroz L; Cesbron J; Racle J; Harari A
    Cell Syst; 2023 Jan; 14(1):72-83.e5. PubMed ID: 36603583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma.
    Linnemann C; van Buuren MM; Bies L; Verdegaal EM; Schotte R; Calis JJ; Behjati S; Velds A; Hilkmann H; Atmioui DE; Visser M; Stratton MR; Haanen JB; Spits H; van der Burg SH; Schumacher TN
    Nat Med; 2015 Jan; 21(1):81-5. PubMed ID: 25531942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCR contact residue hydrophobicity is a hallmark of immunogenic CD8+ T cell epitopes.
    Chowell D; Krishna S; Becker PD; Cocita C; Shu J; Tan X; Greenberg PD; Klavinskis LS; Blattman JN; Anderson KS
    Proc Natl Acad Sci U S A; 2015 Apr; 112(14):E1754-62. PubMed ID: 25831525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitive and frequent identification of high avidity neo-epitope specific CD8
    Bobisse S; Genolet R; Roberti A; Tanyi JL; Racle J; Stevenson BJ; Iseli C; Michel A; Le Bitoux MA; Guillaume P; Schmidt J; Bianchi V; Dangaj D; Fenwick C; Derré L; Xenarios I; Michielin O; Romero P; Monos DS; Zoete V; Gfeller D; Kandalaft LE; Coukos G; Harari A
    Nat Commun; 2018 Mar; 9(1):1092. PubMed ID: 29545564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in a dominant Nef epitope of simian immunodeficiency virus diminish TCR:epitope peptide affinity but not epitope peptide:MHC class I binding.
    Cale EM; Bazick HS; Rianprakaisang TA; Alam SM; Letvin NL
    J Immunol; 2011 Sep; 187(6):3300-13. PubMed ID: 21841125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitope.
    Ebrahimi-Nik H; Moussa M; Englander RP; Singhaviranon S; Michaux J; Pak H; Miyadera H; Corwin WL; Keller GLJ; Hagymasi AT; Shcheglova TV; Coukos G; Baker BM; Mandoiu II; Bassani-Sternberg M; Srivastava PK
    Nat Commun; 2021 Nov; 12(1):6423. PubMed ID: 34741035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steric recognition of T-cell receptor contact residues is required to map mutant epitopes by immunoinformatical programmes.
    Hsu SC; Chang CP; Tsai CY; Hsieh SH; Wu-Hsieh BA; Lo YS; Yang JM
    Immunology; 2012 Jun; 136(2):139-52. PubMed ID: 22121944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro proteasome processing of neo-splicetopes does not predict their presentation in vivo.
    Willimsky G; Beier C; Immisch L; Papafotiou G; Scheuplein V; Goede A; Holzhütter HG; Blankenstein T; Kloetzel PM
    Elife; 2021 Apr; 10():. PubMed ID: 33875134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interdisciplinary analysis of HIV-specific CD8+ T cell responses against variant epitopes reveals restricted TCR promiscuity.
    Hoof I; Pérez CL; Buggert M; Gustafsson RK; Nielsen M; Lund O; Karlsson AC
    J Immunol; 2010 May; 184(9):5383-91. PubMed ID: 20363973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Prediction of the Landscape of T Cell Epitope Immunogenicity in Sequence Space.
    Ogishi M; Yotsuyanagi H
    Front Immunol; 2019; 10():827. PubMed ID: 31057550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis E Virus (HEV)-Specific T Cell Receptor Cross-Recognition: Implications for Immunotherapy.
    Soon CF; Zhang S; Suneetha PV; Antunes DA; Manns MP; Raha S; Schultze-Florey C; Prinz I; Wedemeyer H; Sällberg Chen M; Cornberg M
    Front Immunol; 2019; 10():2076. PubMed ID: 31552033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining virus-specific CD8+ TCR repertoires for therapeutic regeneration of T cells against chronic hepatitis E.
    Soon CF; Behrendt P; Todt D; Manns MP; Wedemeyer H; Sällberg Chen M; Cornberg M
    J Hepatol; 2019 Oct; 71(4):673-684. PubMed ID: 31203151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity in patients with malignant tumor.
    Tomita Y; Yuno A; Tsukamoto H; Senju S; Kuroda Y; Hirayama M; Irie A; Kawahara K; Yatsuda J; Hamada A; Jono H; Yoshida K; Tsunoda T; Kohrogi H; Yoshitake Y; Nakamura Y; Shinohara M; Nishimura Y
    Clin Cancer Res; 2013 Aug; 19(16):4508-20. PubMed ID: 23714729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T Cell Epitope Prediction and Its Application to Immunotherapy.
    Schaap-Johansen AL; Vujović M; Borch A; Hadrup SR; Marcatili P
    Front Immunol; 2021; 12():712488. PubMed ID: 34603286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen identification for HLA class I- and HLA class II-restricted T cell receptors using cytokine-capturing antigen-presenting cells.
    Lee MN; Meyerson M
    Sci Immunol; 2021 Jan; 6(55):. PubMed ID: 33483338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-Scan: A Genome-wide Method for the Systematic Discovery of T Cell Epitopes.
    Kula T; Dezfulian MH; Wang CI; Abdelfattah NS; Hartman ZC; Wucherpfennig KW; Lyerly HK; Elledge SJ
    Cell; 2019 Aug; 178(4):1016-1028.e13. PubMed ID: 31398327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus-cross-reactive TCR gene-modified T cells: a model for immunotherapy against diseases with genomic instability.
    Spear TT; Riley TP; Lyons GE; Callender GG; Roszkowski JJ; Wang Y; Simms PE; Scurti GM; Foley KC; Murray DC; Hellman LM; McMahan RH; Iwashima M; Garrett-Mayer E; Rosen HR; Baker BM; Nishimura MI
    J Leukoc Biol; 2016 Sep; 100(3):545-57. PubMed ID: 26921345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.